Additionally, in vivo experiments demonstrate that silencing CDCA3 inhibits T24 BLCA tumor growth, whereas intraperitoneal injection of pyruvate restores the proliferation of sh-CDCA3 T24 cells (Fig. 1H-M). The gene discussed is CDCA3; the disease is bladder transitional cell carcinoma.